Image

Identification and Characterisation of Sleep Disorders in a Population of Patients With Non-small Cell Lung Cancer

Identification and Characterisation of Sleep Disorders in a Population of Patients With Non-small Cell Lung Cancer

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This exploratory study will identify and characterise disorders frequently reported by patients as contributing to or altering their quality of life. This will enable a decision tree to be drawn up for diagnosis, referral and treatment of the sleep disorders collected, tailored to patients in this population.

This decision tree should help to improve the management of patients with a cancer diagnosis presenting with sleep disorders.

Eligibility

Inclusion Criteria:

  • Patient aged 18 and over.
  • Being monitored and treated for non-small cell lung cancer.
  • With or without ongoing cancer-specific treatment. With no neurocognitive impairment (MoCA test score ≥26/30).
  • With a clinically assessed life expectancy of more than 3 months (Royal Marsden Hospital 0-1) and general health (ECOG <2).
  • Able to understand the study documents written in French
  • Able to complete the study questionnaires written in French.
  • Contactable by telephone throughout the study
  • Affiliated to a social security scheme or entitled beneficiary
  • Not opposed to taking part in the study

Exclusion Criteria:

  • Patient refusing to take part in the study
  • With a mental illness of the psychosis type monitored and treated prior to the study
  • Patient under guardianship or curatorship
  • Patient under court protection

Study details
    Cell Lung Cancer
    Sleep Disorders

NCT06495346

University Hospital, Strasbourg, France

21 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.